Vilazodone: all 26 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study of Vilazodone in Pediatric Patients With Major Depressive DisorderCompletedNCT02436239Phase 3Results posted
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)CompletedNCT02372799Phase 3Results posted
• Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With VilazodoneCompletedNCT02015546Phase 3Results posted
• Vilazodone for Separation Anxiety DisorderCompletedNCT01999920Phase 4Results posted
• Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderCompletedNCT01878292Phase 3Results posted
• Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety DisorderCompletedNCT01844115Phase 3Results posted
• Vilazodone for Corticosteroid-Induced Memory ImpairmentCompletedNCT01828515Phase 2Results posted
• Double-Blind Treatment of Major Depressive Disorder With VilazodoneCompletedNCT01742832Phase 2Results posted
• Vilazodone for Menopausal Hot FlashesCompletedNCT01680900Not applicableResults posted
• Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety DisorderCompletedNCT01629966Phase 3Results posted
• Vilazodone for Treatment of Geriatric DepressionCompletedNCT01608295Phase 4Results posted
• Vilazodone Treatment for Marijuana DependenceCompletedNCT01574183Phase 2Results posted
• Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive DisorderCompletedNCT01473394Phase 4Results posted
• Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01473381Phase 4Results posted
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)CompletedNCT00683592Phase 3Results posted
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)CompletedNCT00644358Phase 3Results posted
• Acute Effect of Polyphenols Supplementation on Endothelial Function and Exercise Related Markers, in Physically Active Healthy Volunteers.Active, not recruitingNCT07518758Not applicable
• Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic EndometritisStatus unknownNCT05205993Phase 2
• Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or PlaceboCompletedNCT02097147Phase 1
• The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar DepressivesWithdrawnNCT02028026Phase 4
• Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?TerminatedNCT01856127Phase 4
• Vilazodone for the Treatment of Posttraumatic Stress DisorderCompletedNCT01715519Phase 4
• Study of Vilazodone to Treat Social Anxiety DisorderStatus unknownNCT01712321Not applicable
• Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01573598Phase 4
• Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderCompletedNCT00290914Phase 2
• Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With ResponseCompletedNCT00285376Phase 3

← Vilazodone overview